Skip to main content

Table 2 Overall survival in AFD, TMB and Kaplan–Meier estimates in the training group

From: Allele frequency deviation (AFD) as a new prognostic model to predict overall survival in lung adenocarcinoma (LUAD)

Variable Low-value group (n = 40) High-value group (n = 14)
AFD
 Deaths—no. (%)a 4 6
 Data censoredb 36 8
 Median overall survival—mo (95% CI) NE NE
 The overall survival (95% CI) by Kaplan–Meier estimation
 12 mo 95% (88.5–100) 78.6% (59.8–100)
 31 mo 89.7% (80.6–99.8) 64.3% (43.5–95)
 35 mo NA 56.2% (35.2–90)
TMB
 Deaths—no. (%)a 5 5
 Data censoredb 35 9
 Median overall survival—mo (95% CI) NE NE
 The overall survival (95% CI) by Kaplan–Meier estimation
 13 mo 92.5(84.7–100) 78.6 (59.8–100)
 31 mo 89.9 (80.9–99.8) 62.5 (41–95.3)
 35 mo 87.1 (77.2–98.3) NA
  1. aRepresent the hazard ratio for death
  2. bIndicate the date for censorship of patients on the date the patient was last known to be alive
  3. NA indicate that there is no available events
  4. NE represent that the value could not be estimated